Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04895956 · ClinicalTrials.gov registry record · Phase 4

Intra-sheath vs Extra-sheath Injection for De Quervain's Tenosynovitis

A Phase 4 study of De Quervain Tenosynovitis, sponsored by University of California, Davis.

Recruiting
Registry status
Phase 4
Development phase
80
Enrollment target
1
Study location

NCT04895956 is a Phase 4 study of De Quervain Tenosynovitis that is actively recruiting participants, run by University of California, Davis. The registered enrollment target is 80 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04895956, a Phase 4 study of De Quervain Tenosynovitis, is actively recruiting participants, sponsored by University of California, Davis.

RECRUITING
Registry status
Phase 4
Development phase
80 participants
Enrollment target
1
Study location

Study Summary

The aim of the study is to determine whether or not extra-sheath steroid injections are inferior to intra-sheath steroid injections in the treatment of DeQuervain's Tenosynovitis. Patients will be randomized to either the intra-sheath group or the extra-sheath group and their pre-injection level of pain will be assessed using the visual analog scale. Appropriate injections will then be administered by 1 of 3 UC Davis hand surgeons. Six weeks post injection the patients will be reassessed using the visual analog scale and their score at 6 weeks will be compared to their pre-injection score.

Conditions Studied

Interventions

  • DEVICE Ultrasound
  • PROCEDURE Intra-sheath injection
  • PROCEDURE Extra-sheath injection

Study Locations (1)

California

  • UC Davis Health, Department of Orthopaedics - Sacramento

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2022-01-24
Est. Completion 2026-06-01
Phase Phase 4

Sponsor

University of California, Davis

657 total trials

What the Registry Record Tells You About NCT04895956

The ClinicalTrials.gov registry entry for NCT04895956 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with De Quervain Tenosynovitis appearing as the primary indexed condition, and to 3 interventions - of which Ultrasound is the first listed.

NCT04895956 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT04895956 about?

NCT04895956 is a clinical study titled "Intra-sheath vs Extra-sheath Injection for De Quervain's Tenosynovitis". The aim of the study is to determine whether or not extra-sheath steroid injections are inferior to intra-sheath steroid injections in the treatment of DeQuervain's Tenosynovitis. Patients will be randomized to either the intra-sheath group or the extra-sheath group and their pre-injection level of...

What is the current status of trial NCT04895956?

This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 80 participants. The study started on 2022-01-24. Estimated completion is 2026-06-01.

What conditions does trial NCT04895956 study?

This clinical trial studies the following conditions: De Quervain Tenosynovitis.

What interventions are being tested in trial NCT04895956?

The interventions under investigation include: Ultrasound (DEVICE), Intra-sheath injection (PROCEDURE), Extra-sheath injection (PROCEDURE).

Who is sponsoring clinical trial NCT04895956?

This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04895956 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.